Kura Oncology (KURA) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Kura Oncology (KURA) Stock Forecast for 2024–2028. Sell or Buy?

Updated: June 23, 2024 (20:58)

Sector: Healthcare

The share price of Kura Oncology, Inc. (KURA) now

Latest session on the 21st of June for
Kura Oncology, Inc. is positive
Trading Volume: 2545312
Open: 20.38 /  High: 21.26 /  Low: 20.38
What analysts predict: $30.42
52-week High/Low: $24.17 / $7.41

50/200 Day Moving Average: $20.53 / $15.77

This figure corresponds to the Average Price over the previous 50/200 days. For Kura Oncology stocks, the 50-day moving average is the support level today.

For Kura Oncology stocks, the 200-day moving average is the support level today.

Are you interested in Kura Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kura Oncology stock price in 2024, 2025, 2026, 2027, 2028. How much will one Kura Oncology share be worth in 2024 - 2028?

When should I take profit in Kura Oncology stock? When should I record a loss on Kura Oncology stock? What are analysts' forecasts for Kura Oncology stock? What is the future of Kura Oncology stock? We forecast Kura Oncology stock performance using neural networks based on historical data on Kura Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kura Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kura Oncology shares. This happens once a day.


Historical and forecast chart of Kura Oncology stock

The chart below shows the historical price of Kura Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kura Oncology stock price can be found in the table below.

Long-term forecasts by years.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Kura Oncology daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 25 21.40 21.28 21.60 1.49
Jun 26 21.60 21.41 21.94 2.50
Jun 27 21.74 21.44 21.89 2.09
Jun 28 21.32 21.09 21.57 2.26
Jun 29 21.55 21.25 21.67 1.95
Jun 30 21.37 21.10 21.53 2.07
Jul 01 21.53 21.39 21.79 1.91
Jul 02 21.38 21.29 21.61 1.51
Jul 03 21.33 21.11 21.56 2.12
Jul 04 21.48 21.14 21.57 1.99
Jul 05 21.47 21.21 21.68 2.19
Jul 06 21.89 21.65 22.10 2.10
Jul 07 21.89 21.58 22.00 1.97
Jul 08 21.81 21.64 22.11 2.18
Jul 09 21.79 21.47 21.90 1.99
Jul 10 22.02 21.88 22.15 1.23
Jul 11 21.95 21.60 22.09 2.28
Jul 12 22.26 22.15 22.52 1.69
Jul 13 21.87 21.70 21.98 1.31
Jul 14 21.73 21.54 21.82 1.29
Jul 15 21.82 21.67 22.02 1.63
Jul 16 21.84 21.55 22.08 2.45
Jul 17 21.97 21.66 22.26 2.76
Jul 18 21.91 21.61 22.15 2.47
Jul 19 22.02 21.74 22.22 2.23
Jul 20 22.06 21.91 22.21 1.39
Jul 21 21.70 21.59 21.90 1.41
Jul 22 21.64 21.47 21.84 1.75
Jul 23 21.31 21.10 21.41 1.49
Jul 24 21.51 21.21 21.81 2.82

Kura Oncology Daily Price Targets


Kura Oncology Stock Forecast 06-25-2024.

Forecast target price for 06-25-2024: $21.40.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.467%.
Pessimistic target level: 21.28
Optimistic target level: 21.60

Kura Oncology Stock Forecast 06-26-2024.

Forecast target price for 06-26-2024: $21.60.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.442%.
Pessimistic target level: 21.41
Optimistic target level: 21.94

Kura Oncology Stock Forecast 06-27-2024.

Forecast target price for 06-27-2024: $21.74.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.047%.
Pessimistic target level: 21.44
Optimistic target level: 21.89

Kura Oncology Stock Forecast 06-28-2024.

Forecast target price for 06-28-2024: $21.32.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.214%.
Pessimistic target level: 21.09
Optimistic target level: 21.57

Kura Oncology Stock Forecast 06-29-2024.

Forecast target price for 06-29-2024: $21.55.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.909%.
Pessimistic target level: 21.25
Optimistic target level: 21.67

Kura Oncology Stock Forecast 06-30-2024.

Forecast target price for 06-30-2024: $21.37.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.024%.
Pessimistic target level: 21.10
Optimistic target level: 21.53

KURA (KURA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jul. 22.98 21.43 24.15 11.26
Aug. 24.83 23.77 25.74 7.65
Sep. 23.48 21.46 24.18 11.23
Oct. 23.08 22.09 24.31 9.13
Nov. 23.02 22.21 25.03 11.24
Dec. 24.34 22.15 25.10 11.72

Kura Oncology forecast for this year


Kura Oncology Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $22.9816. Pessimistic: $21.43. Optimistic: $24.15


Kura Oncology Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $24.834. Pessimistic: $23.77. Optimistic: $25.74


Kura Oncology Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $23.478. Pessimistic: $21.46. Optimistic: $24.18


Kura Oncology Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $23.0813. Pessimistic: $22.09. Optimistic: $24.31


Kura Oncology Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $23.0212. Pessimistic: $22.21. Optimistic: $25.03


Kura Oncology Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $24.3381. Pessimistic: $22.15. Optimistic: $25.10



Kura Oncology (KURA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 27.22 26.12 28.14 7.17
Feb 26.44 25.68 29.02 11.49
Mar 25.13 23.30 25.95 10.20
Apr 24.84 22.80 26.97 15.44
May 25.84 23.99 27.65 13.24
Jun 24.50 21.95 26.47 17.08
Jul 24.91 22.61 26.04 13.18
Aug 23.97 22.72 24.91 8.76
Sep 26.74 25.08 29.32 14.47
Oct 27.40 25.05 29.65 15.50
Nov 28.22 26.17 30.90 15.32
Dec 31.05 29.27 33.35 12.22

Kura Oncology (KURA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 32.95 31.19 33.80 7.73
Feb 32.86 31.96 34.78 8.11
Mar 29.66 28.11 31.35 10.33
Apr 31.24 29.29 32.05 8.62
May 31.97 30.35 33.01 8.06
Jun 34.55 32.84 36.97 11.18
Jul 35.49 33.92 37.06 8.47
Aug 34.52 32.50 37.35 12.98
Sep 37.26 35.08 39.53 11.27
Oct 38.37 35.48 40.67 12.76
Nov 34.53 31.39 36.33 13.59
Dec 33.45 31.50 35.50 11.27

Kura Oncology (KURA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 31.28 29.98 33.07 9.35
Feb 35.34 33.41 37.69 11.34
Mar 37.41 34.79 38.97 10.73
Apr 41.01 37.07 42.93 13.66
May 41.92 38.05 45.19 15.80
Jun 46.11 43.90 50.61 13.27
Jul 50.07 47.73 51.83 7.91
Aug 51.11 45.80 53.30 14.09
Sep 48.59 44.35 49.85 11.02
Oct 51.30 48.84 53.84 9.29
Nov 50.64 48.00 53.66 10.55
Dec 50.77 45.75 52.48 12.83

Kura Oncology (KURA) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 52.48 49.55 57.05 13.15
Feb 52.14 46.92 57.23 18.00
Mar 58.92 56.62 61.14 7.39
Apr 57.08 54.49 61.31 11.13
May 63.17 61.03 68.34 10.69
Jun 63.00 59.65 65.79 9.34
Jul 70.13 66.21 72.04 8.10
Aug 78.15 74.60 81.20 8.13
Sep 84.55 76.31 91.37 16.48
Oct 76.64 70.26 83.91 16.27
Nov 76.74 70.55 81.73 13.67
Dec 79.03 75.95 82.32 7.74

Kura Oncology information and performance

Kura Oncology Address

3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US

Market Capitalization: 1 570 463 000 $

Market capitalization of the Kura Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KURA shares in the company outstanding by the market price of one share.

EBITDA: -182 812 992 $

EBITDA of Kura Oncology is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.17

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -7.16

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 76181000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.